Raleigh Capital Management Inc. Trims Position in Danaher Co. (NYSE:DHR)

Raleigh Capital Management Inc. lowered its holdings in Danaher Co. (NYSE:DHR) by 5.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,353 shares of the conglomerate’s stock after selling 85 shares during the period. Raleigh Capital Management Inc.’s holdings in Danaher were worth $311,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. Coronation Fund Managers Ltd. grew its holdings in shares of Danaher by 29.9% during the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after purchasing an additional 1,470 shares during the period. Public Sector Pension Investment Board lifted its position in Danaher by 119.8% during the second quarter. Public Sector Pension Investment Board now owns 19,503 shares of the conglomerate’s stock valued at $4,873,000 after buying an additional 10,628 shares in the last quarter. APG Asset Management US Inc. grew its stake in Danaher by 4.4% during the second quarter. APG Asset Management US Inc. now owns 211,565 shares of the conglomerate’s stock worth $51,730,000 after buying an additional 8,908 shares during the period. APG Asset Management N.V. increased its position in shares of Danaher by 13.6% in the second quarter. APG Asset Management N.V. now owns 531,544 shares of the conglomerate’s stock worth $123,915,000 after acquiring an additional 63,712 shares in the last quarter. Finally, Daymark Wealth Partners LLC raised its stake in shares of Danaher by 3.0% in the 2nd quarter. Daymark Wealth Partners LLC now owns 16,498 shares of the conglomerate’s stock valued at $4,122,000 after acquiring an additional 485 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have commented on DHR shares. TD Cowen boosted their price objective on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research report on Friday, December 13th. UBS Group lowered their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Evercore ISI boosted their target price on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, Scotiabank started coverage on shares of Danaher in a research note on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Six equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $285.55.

Danaher Trading Up 0.6 %

Shares of NYSE:DHR opened at $245.73 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock’s 50-day moving average is $234.90 and its 200-day moving average is $253.47. The company has a market cap of $177.49 billion, a P/E ratio of 46.90, a P/E/G ratio of 4.43 and a beta of 0.83. Danaher Co. has a 52-week low of $225.42 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the firm earned $2.02 EPS. The business’s revenue was up 3.1% on a year-over-year basis. Equities research analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. Danaher’s payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.